RPRX: Royalty Pharma and Zealand Pharma Enter Funding Agreement
Royalty Pharma and Zealand Pharma enter into rusfertide funding agreement for $100 million
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.